Back to Search
Start Over
Are the recommendations for post-operative antibiotics in patients with grade I or II acute calculous cholecystitis being applied in clinical practice?
- Source :
- HPB, HPB, Wiley, 2020, 22 (7), pp.1051-1056. ⟨10.1016/j.hpb.2019.10.2442⟩
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
-
Abstract
- Background There is a level-1 evidence indicating that postoperative antibiotics are unnecessary following cholecystectomy for grade I or II acute calculous cholecystitis (ACC). We wanted to evaluate the applications of this recommendation in clinical practice four years after the original publication in ABCAL-participating centers. Methods A retrospective analysis of patients operated for grade I or II ACC from January to December 2016 in ABCAL-participating centers was performed. Inclusion criteria were the same as for the ABCAL-study. The primary endpoint was the postoperative antibiotic administration rate. The secondary endpoints were postoperative outcomes. Results Of the 283 patients included, 64% received postoperative antibiotics. Only 19% received antibiotics after POD1. The perioperative outcomes were similar between those that did or did not receive antibiotics after POD1. The median [range] length of stay was significantly shorter in patients who did not receive postoperative antibiotics (4 days [1–20]) compared to the others (6 days [1–50], p > 0.001). Conclusion Despite strong recommendations included in the Tokyo 2018 guidelines, the results of the ABCAL-study are poorly applied even if the absence of postoperative antibiotics has no impact on morbidity. It is important to stress that postoperative antibiotics are not necessary after cholecystectomy for grade I or II ACC.
- Subjects :
- MESH: Cholecystectomy
medicine.medical_specialty
medicine.drug_class
medicine.medical_treatment
Cholecystitis, Acute
Antibiotics
030230 surgery
MESH: Length of Stay
03 medical and health sciences
Postoperative Complications
0302 clinical medicine
MESH: Postoperative Period
MESH: Anti-Bacterial Agents
MESH: Postoperative Complications
medicine
Clinical endpoint
Humans
Cholecystectomy
In patient
Postoperative Period
Post operative
10. No inequality
Retrospective Studies
MESH: Treatment Outcome
MESH: Humans
Hepatology
business.industry
Gastroenterology
MESH: Cholecystitis, Acute
MESH: Retrospective Studies
[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
Perioperative
Length of Stay
[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences
medicine.disease
[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology
Anti-Bacterial Agents
3. Good health
Surgery
Clinical Practice
Treatment Outcome
MESH: Cholecystectomy, Laparoscopic
Cholecystectomy, Laparoscopic
030220 oncology & carcinogenesis
Cholecystitis
business
Subjects
Details
- ISSN :
- 1365182X
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- HPB
- Accession number :
- edsair.doi.dedup.....3df2992e9200ace43b33c5c1bee0459e